KTOS Backlog Expansion Unchanged by Valuation and Cash Flow Risks

What happened

Kratos Defense's Q1 2026 revenue grew 22.6% year-over-year to $371 million and total backlog reached $2.011 billion, but operating cash flow was negative $28.5 million and free cash flow negative $48.4 million, with DSO rising to 130 days. Since then, the company has announced a $2.08 billion backlog and plans to expand production capacity through 2028, including a target of approximately 40 Valkyries annually by end-2027. However, the unmanned segment generated only $1.3 million of segment operating income on $82.6 million of revenue in Q1, and the largest near-term Air Force Collaborative Combat Aircraft production awards went to Anduril and General Atomics rather than Kratos. At the current stock price around $47, KTOS trades at 273.9x earnings and 73.2x EV/EBITDA, embedding expectations that funded backlog conversion, working-capital improvement, and new Valkyrie follow-ons materialize over the next two quarters. The August 4, 2026 Q2 report and subsequent Q3 update will be critical in determining whether the scale-up narrative translates into positive operating cash flow and expanded unmanned production commitments.

Implication

Near-term, the stock's valuation remains stretched relative to current profitability, with a 273.9x P/E and 73.2x EV/EBITDA, so any disappointment in Q2 could trigger further multiple compression. Key metrics to watch include funded backlog growth (Q1 was $1.457 billion), DSO staying below 130 days, and inventory and unbilled receivables not outpacing revenue. Additionally, new unmanned bookings tied to Valkyrie or CCA follow-ons would counter the June 2026 Air Force award exclusion and support the capacity expansion thesis. Despite the balance sheet's $1.46 billion cash and zero debt, heavy dilution to 187.5 million shares means per-share execution risk remains elevated, and free cash flow is guided to negative $85–$105 million in FY26. Therefore, investors should wait for evidence of funded backlog conversion and positive operating cash flow before considering entry, while a pullback toward the $42 attractive-entry level could offer a more favorable risk-reward.

Thesis delta

The Zacks article highlighting a $2.08 billion backlog and capacity expansion is consistent with the existing bull case but does not alter the fundamental thesis. The key risks identified in the deep value report—negative free cash flow, thin unmanned margins, and exclusion from primary Air Force CCA awards—remain unresolved. Thus, the WAIT rating and scenarios (base value $48, bear $34, bull $62) are unchanged, with the next catalyst being the Q2 2026 report.